Lupin gets US health regulator nod for anti-allergic tablets

03 Nov 2010 Evaluate

Drug firm Lupin has been granted final approval by the United states Food and Drug Administration (USFDA) for antihistamine Desloratadine tablets, used for treating allergies. The approval has been given to Lupin Pharmaceuticals, Lupin's wholly owned US subsidiary for Desloratadine tablets in the strength of 5 mg.

 

Desloratadine tablets 5 mg are generic version of Clarinex tablets 5 mg of US-based drug major Schering-Plough. According to IMS Health, clarinex tablets have recorded sales of $229 million for this year. The company has filed 132 abbreviated new drug applications for this financial year, of which 45 have been approved by the USFDA.

crackcrack

Lupin Share Price

1581.20 -6.70 (-0.42%)
03-Jun-2024 14:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1463.55
Dr. Reddys Lab 5791.00
Cipla 1448.85
Zydus Lifesciences 1032.30
Lupin 1581.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.